Robert Martin, MDEnriched profile
The Sam and Lolita Weakley Endowed Chair in Surgical Oncology; Professor, Department of Surgery; Director, Division of Surgical Oncology · University of Louisville School of Medicine, Department of Surgery / James Graham Brown Cancer Center
Overview
Updated 14 Jul 2026
Robert C.G. Martin II, MD, is The Sam and Lolita Weakley Endowed Chair in Surgical Oncology at University of Louisville School of Medicine, Department of Surgery / James Graham Brown Cancer Center. The public record shows 102 publications with 11,308 citations (h-index 45), centered on Pancreatic Cancer, Colorectal Cancer, Hepatobiliary Cancer. It also documents an investigator role on 14 registered clinical trials, industry payments reported by 23 companies, 1 NIH-funded awards (2008–2009).
- Top research focus: Pancreatic Cancer
- 14 registered trials on ClinicalTrials.gov
- Open Payments reporting from 23 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 14 registered studies on ClinicalTrials.gov. The most recent:
- Adjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation Alone
Sponsor: Robert C. Martin
InvestigatorPhase 2RecruitingNCT06526338 - Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
Sponsor: University of Louisville
InvestigatorPhase 1RecruitingNCT03484299 - A Study of Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablation Intra-Hepatic Cholangiocarcinoma
Sponsor: University of Louisville
InvestigatorPhase 3WithdrawnNCT03081039
Industry payments
Updated 14 Jul 2026
23 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AngioDynamics, Inc.Program year202516 payments$36,340openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- Galvanize Therapeutics, IncProgram year20251 payment
NIH funding
Updated 14 Jul 2026
1 NIH research award on record, funded 2008–2009 per NIH RePORTER. The latest:
- From single molecule to microfluidic 3D tissue platforms: novel multiscale tools to investigate hyper-stimulated immune cells in the circulation
Michigan State University
FY2026$580,893R01NS105888 - From single molecule to microfluidic 3D tissue platforms: novel multiscale tools to investigate hyper-stimulated immune cells in the circulation
Michigan State University
FY2025$579,919R01NS105888 - An Enhanced Neurovascular Model with Scanning Conductance Imaging of Cell Junctions to Determine the Role of Matrix Metalloproteases in Multiple Sclerosis
Michigan State University
FY2025$534,964R01NS137462
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
401 E. Chestnut St., Suite 710, Louisville, KY 40202
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rcgmartinmd.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rcgmartinmd.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rcgmartinmd.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rcgmartinmd.com ↗
Editorial & leadership rolesjournal and society appointments
- Director
Division of Surgical Oncology, University of Louisville Department of Surgery
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →louisville.edu ↗ - Faculty member
James Graham Brown Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rcgmartinmd.com ↗ - Principal Investigator
multiple clinical trials in hepato-pancreatico-biliary cancer
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rcgmartinmd.com ↗
Awards & honorshonors on the public record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rcgmartinmd.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rcgmartinmd.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rcgmartinmd.com ↗
Secondary affiliationsappointments beyond the home institution
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →immunophotonics.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/robert-martin-md-e5e1e14a
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Facebook
facebook.com/profile.php
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - LinkedIn
linkedin.com/in/robert-c-g-martin-m-d-ph-d-25468a31
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
Mentions by otherswhere others cite or feature them
- Facebook
facebook.com/UofLHealth/videos/get-to-know-surgical-oncologist-dr-robert-martin/988161812118498
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Eric Van Cutsem, MD, PhD
Universitair Ziekenhuis Leuven
- 1,845
- publications
- 177
- h-index
- 14
- trials
Josep Tabernero, MD, PhD
Vall d'Hebron Institut de Recerca
- 2,704
- publications
- 148
- h-index
- 19
- trials
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
- 1,745
- publications
- 154
- h-index
- 22
- trials
Charles Fuchs, MD, MPH
Yale Cancer Center
- 1,721
- publications
- 172
- h-index
- 7
- trials